D allele of G1057D polymorphism was associated with increased risk of CAD (OR: 1.44, CI-1.08-1.92, P = 0.01) in overall population as well as in individuals with high
BMI, WC, WHR and normal range of triglycerides and cholesterol. For PPAR gamma variants (Pro12Ala,C1431T), no statistical significant association was observed in the allelic and genotypic frequencies of cases and controls but TT genotype (C1431T) and G allele ( Pro12Ala) Selleckchem GW4869 conferred protection against CAD in individuals with high cholesterol and normal HDL-C respectively. Statistically significant difference in the different genotypic combinations of IRS1 (G972R) with IRS2 (G1057D) and PPAR gamma (C1431T) confirmed their role in susceptibility to CAD in Punjabi population from North-west India.”
“Aims: To
assess plasma concentrations of folic acid, vitamin B12, and total plasma homocysteine (tHCY) during fasting and after methionine load in young patients with Type 1 diabetes mellitus (T1DM). Methods: We enrolled 41 young patients with T1DM without any sign of microvascular complications and 123 healthy controls in a 1:3 case-control study. Fasting and post-methionine load (PML) DMXAA cost tHCY, folic acid, and vitamin B12 levels were measured in both groups. Data regarding chronological age, metabolic control (assessed by mean values of glycated hemoglobin in the last 12 months) and disease duration were also recorded. Results: Fasting and PML tHCY levels were significantly lower in patients than
in controls: 7.3 +/- 2.7 mu mol/l vs 8.3 +/- 2.5 mu mol/l (p=0.01), and 16.7 +/- 5.8 mu mol/l vs 17.3 +/- 4.3 mu mol/l (p=0.01), respectively. No correlation was found between fasting and PML tHCY levels and chronological age, disease duration, metabolic control, and insulin requirement. Patients had significantly higher vitamin B12 levels compared to controls: 767 +/- 318 pg/ml vs 628 +/- 236 pg/ml (p=0.003), while folic acid turned out to be lower in patients than in controls: 5.3 +/- 1.9 nmol/l vs 7.5 +/- 2.6 nmol/l (p<0.0001). FDA-approved Drug Library mouse Conclusions: Adolescents and young adults with T1DM without microvascular complications showed lower tHCY both during fasting and after methionine load. Lower folate concentrations in these patients might benefit from food fortification. (J. Endocrinol. Invest. 33: 297-299, 2010) (C) 2010, Editrice Kurtis”
“BNBackground/Aims: Cirrhotic patients chronically treated with beta-blockers who achieve a decrease of hepatic venous pressure gradient (HVPG) >= 20% from baseline or to <= 12 mmHg have a marked reduction of first bleeding or re-bleeding. However, two HVPG measurements are needed to evaluate response. This study was aimed at investigating the predictive role of acute HVPG response to i.v. propranolol for bleeding and survival.\n\nMethods: We retrospectively studied 166 cirrhotic patients with varices with HVPG response to i.v. propranolol (0.15 mg/kg).